Specifications Molecular Formula CHNO Molecular Weight 5302.3 g/mol Receptor Targets GLP-1R + GIPR + GCGR (triple agonist) Form Lyophilized white powder Storage (unopened) -20C, protected from light Storage (reconstituted) 2-8C, use within 30 days Reconstitution & storage Add 2 mL of bacteriostatic water to the 10 mg vial for a 5 mg/mL working concentration
Retatrutide Retatrutide is a synthetic research peptide currently being investigated for its role in metabolic regulation in preclinical models
In any case, be safe and take it slow to preserve surgical gains
Other GLP-1 receptor agonists combining retatrutide with another GLP-1 RA is not recommended, as this is not supported by clinical evidence and may increase the risk of adverse effects
Burdyga, G., Varro, A., Dimaline, R., Thompson, D